Off the wire
S.Korea's import prices rise for 2 months on higher oil prices  • Tokyo shares open higher on strong U.S. stocks, weak yen  • Aussies wake up with shiver on Wednesday  • Xinhua world news summary at 0030 GMT, July 13  • Bolivia beat Cuba to secure Davis Cup playoffs spot  • Brazilian football star Formiga set to take part in her sixth Olympic Games  • Team USA name Olympic track and field squad  • Brazil playmaker Ganso set for Sevilla move  • Dollar changes hands in upper 104 yen zone in early Tokyo trading  • US vice-president Joe Biden to visit Aust'n city of Melbourne  
You are here:   Home

Dementia vaccine may be just years away, Aussie scientists

Xinhua, July 13, 2016 Adjust font size:

A vaccine for the degenerative disease dementia may be just three to five years away according to Australian researchers, following a "breakthrough discovery" which could prevent up to 7.5 million new cases of the condition every year.

Dementia is a syndrome which affects a person's memory, thinking and the ability to perform day-to-day tasks, and is especially prevalent in older people, however researchers from the Flinders University in Adelaide believe they have found a way to prevent it before it strikes, thanks to a collaboration with research teams at the Institute of Molecular Medicine and University of California.

The Australian researchers believe they have successfully created a vaccine formula which targets the irregular beta-amyloid and tau proteins triggering the onset of the disease.

Flinders University medicine professor Nikolai Petrovsky told News Corp Wednesday that if the breakthrough passes human trialing, it could be available for widespread use within five years.

"If we are successful in (human) clinical trials, in three to five years we could be well on the way to one of the most important developments in recent medical history," Petrovsky said.

He said researchers had targeted the offending cells so effectively that the formula was more likely to be used as a preventative vaccine instead of a treatment.

"It is actually our technology we've developed here in Adelaide that is what has transformed the vaccine to make it powerful enough; we have been able to make it dramatically more potent so it could eventually be used as a preventative measure," Petrovsky said. Endit